Search research articles
Contact Us
Filters
Showing results (21-30 of 108) with videos related to
Page
of 11
Sort By:
Plos One
|
October 3, 2012
Impairment of retrograde neuronal transport in oxaliplatin-induced neuropathy demonstrated by molecular imaging
Dawid Schellingerhout, Lucia G LeRoux, Brian P Hobbs, et al.
Journal of the Royal Statistical Society. Series C, Applied Statistics
|
September 22, 2025
A patient similarity-embedded Bayesian approach to prognostic biomarker inference with application to thoracic cancer immunity
Duo Yu, Meilin Huang, Michael J Kane, et al.
Statistical Methods in Medical Research
|
January 24, 2019
A functional model for classifying metastatic lesions integrating scans and biomarkers
Yuan Wang, Jianhua Hu, Chaan S Ng, et al.
Journal of Applied Statistics
|
August 24, 2019
Spatial Bayesian modeling of GLCM with application to malignant lesion characterization
Xiao Li, Michele Guindani, Chaan S Ng, et al.
Ethics & Human Research
|
November 20, 2019
Reprioritizing Risk and Benefit: The Future of Study Design in Early-Phase Cancer Research
Bryan Anthony Sisk, James Dubois, Brian P Hobbs, et al.
Statistical Methods in Medical Research
|
December 3, 2020
Statistical design considerations for trials that study multiple indications
Alexander M Kaizer, Joseph S Koopmeiners, Nan Chen, et al.
Statistics in Medicine
|
November 10, 2021
A group-sequential randomized trial design utilizing supplemental trial data
Ales Kotalik, David M Vock, Brian P Hobbs, et al.
Nature Reviews. Clinical Oncology
|
June 13, 2020
Histology-agnostic drug development - considering issues beyond the tissue
Roberto Carmagnani Pestana, Shiraj Sen, Brian P Hobbs, et al.
JCO Precision Oncology
|
April 6, 2022
Optimal Sequential Predictive Probability Designs for Early-Phase Oncology Expansion Cohorts
Emily C Zabor, Alexander M Kaizer, Elizabeth Garrett-Mayer, et al.
Biometrics
|
March 3, 2011
Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials
Brian P Hobbs, Bradley P Carlin, Sumithra J Mandrekar, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 108) with videos related to
Sort By:
Page
of 11
Plos One
|
October 3, 2012
Impairment of retrograde neuronal transport in oxaliplatin-induced neuropathy demonstrated by molecular imaging
Dawid Schellingerhout, Lucia G LeRoux, Brian P Hobbs, et al.
Journal of the Royal Statistical Society. Series C, Applied Statistics
|
September 22, 2025
A patient similarity-embedded Bayesian approach to prognostic biomarker inference with application to thoracic cancer immunity
Duo Yu, Meilin Huang, Michael J Kane, et al.
Statistical Methods in Medical Research
|
January 24, 2019
A functional model for classifying metastatic lesions integrating scans and biomarkers
Yuan Wang, Jianhua Hu, Chaan S Ng, et al.
Journal of Applied Statistics
|
August 24, 2019
Spatial Bayesian modeling of GLCM with application to malignant lesion characterization
Xiao Li, Michele Guindani, Chaan S Ng, et al.
Ethics & Human Research
|
November 20, 2019
Reprioritizing Risk and Benefit: The Future of Study Design in Early-Phase Cancer Research
Bryan Anthony Sisk, James Dubois, Brian P Hobbs, et al.
Statistical Methods in Medical Research
|
December 3, 2020
Statistical design considerations for trials that study multiple indications
Alexander M Kaizer, Joseph S Koopmeiners, Nan Chen, et al.
Statistics in Medicine
|
November 10, 2021
A group-sequential randomized trial design utilizing supplemental trial data
Ales Kotalik, David M Vock, Brian P Hobbs, et al.
Nature Reviews. Clinical Oncology
|
June 13, 2020
Histology-agnostic drug development - considering issues beyond the tissue
Roberto Carmagnani Pestana, Shiraj Sen, Brian P Hobbs, et al.
JCO Precision Oncology
|
April 6, 2022
Optimal Sequential Predictive Probability Designs for Early-Phase Oncology Expansion Cohorts
Emily C Zabor, Alexander M Kaizer, Elizabeth Garrett-Mayer, et al.
Biometrics
|
March 3, 2011
Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials
Brian P Hobbs, Bradley P Carlin, Sumithra J Mandrekar, et al.
Page
of 11